humanitarian
Archived signal Translated · Українська · 2–5m lag
Звіт про європейські ліки (EPAR): Vydura, eddegepant, Date of Pritoration: 25/}2022, resize: 9, Status: Authorized
Звіт з питань людських ліків (EPAR) (EDAR): Azantive, ablibercecopet, Date of Pentification: 13/01/2025, revision: 6, Status: Authorized
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewЗвіт про європейські ліки (EPAR): Vydura, eddegepant, Date of Pritoration: 25/}2022, resize: 9, Status: AuthorizedEMA What Is NewЗвіт про європейські ліки (EPAR): Vydura, eddegepant, Date of Pritoration: 25/}2022, resize: 9, Status: AuthorizedEMA What Is NewHuman medicines European public assessment report (EPAR): Instanyl, fentanyl, Date of authorisation: 20/07/2009, Revision: 42, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Instanyl, fentanyl, Date of authorisation: 20/07/2009, Revision: 42, Status: AuthorisedEMA What Is NewЗвіт про лікування людських ліків (EPAR): Costaiv, Incumran, Date of Pritorization: 12/02/2025, consution: 6, Status: AuthorizedEMA What Is NewЗвіт про лікування людських ліків (EPAR): Costaiv, Incumran, Date of Pritorization: 12/02/2025, consution: 6, Status: AuthorizedEMA What Is NewHuman medicines European public assessment report (EPAR): Eklira Genuair, aclidinium bromide, Date of authorisation: 20/07/2012, Revision: 23, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Eklira Genuair, aclidinium bromide, Date of authorisation: 20/07/2012, Revision: 23, Status: AuthorisedEMA What Is NewЗвіт про людські ліки (EPAR): Duaklir Genuair, aclidium bromidi,formoterol, Date of Permissionation: 19/ 11/2014, resize: 18, status: AsistedEMA What Is NewЗвіт про людські ліки (EPAR): Duaklir Genuair, aclidium bromidi,formoterol, Date of Permissionation: 19/ 11/2014, resize: 18, status: AsistedEMA What Is NewHuman medicines European public assessment report (EPAR): Byfavo, remimazolam, Date of authorisation: 26/03/2021, Revision: 11, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Byfavo, remimazolam, Date of authorisation: 26/03/2021, Revision: 11, Status: Authorised2 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources